Skip to main content

Revolution Medicines, Inc.

RVMDW
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001628171

In the last 90 days, Revolution Medicines, Inc. insiders filed 0 open-market purchases and 16 sales; 22 institutions reported holding it in 13F filings for Q2 2026, worth $104.3M in total; no superinvestor holds it.

Other share classesRVMD

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Revolution Medicines, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
16 filings
10 insiders, $76.9M in total
Insiders trading
10
Net value
−$76.9M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Revolution Medicines, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Revolution Medicines, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Anderson Elizabeth MDirector4,333Sep 24, 20263
Mancini AnthonySee Remarks40,352Sep 22, 20267
Sandler Alan B.Chief Development Officer52,868Sep 18, 20261
Kelsey Stephen MichaelSee Remarks286,307Sep 18, 20267
Horn Margaret AChief Operating Officer149,680Sep 18, 20267
Goldsmith Mark ASee Remarks253,342Sep 18, 202613
Cislini JeffSVP & General Counsel52,541Sep 18, 20269
Anders JackChief Financial Officer119,216Sep 18, 20269
Kim Lorence H.Director0IndirectSep 10, 20263
Patel SushilDirector21,656Jul 1, 20262
Borisy AlexisDirector2,340,075Jun 23, 20261
Horning SandraDirector97,765Jun 23, 20261
Clyburn FrankDirector10,929Jun 23, 20261
Borellini FlaviaDirector26,215Jun 23, 20261
Wang XiaolinSee Remarks116,063Mar 19, 20262
Wei LinChief Medical Officer101,366Mar 19, 20262
Schroeder ThiloDirector760,869IndirectDec 9, 20240
Weber BarbaraDirector13,065Oct 10, 20240
Schmidt Eric ThomasDirector21,251Jun 12, 20230
Exter NeilDirector28,815Jun 17, 20220
Tepper Robert I10% Owner5,104,130Jun 10, 20220
Third Rock Ventures III, L.P.10% Owner5,104,130Jun 10, 20220
TRV GP III, LLC10% Owner5,104,130Jun 10, 20220
Third Rock Ventures GP III, L.P.10% Owner5,104,130Jun 10, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 24, 2026 (view filing)6:00 PM ETSep 222 daysAnderson Elizabeth MDirectorSSale−10.1K$193.04−$1.96M−70.1%4.33K after5 lots10b5-1
Sep 22, 2026 (view filing)6:00 PM ETSep 184 daysMancini AnthonySee RemarksSSale−1.76K$196.94−$347.4K−4.2%40.4K after10b5-1
Sep 18, 2026 (view filing)6:06 PM ETSep 162 daysSandler Alan B.Chief Development OfficerSSale−341$199.24−$67.9K−0.6%52.9K after2 lots10b5-1
Sep 18, 2026 (view filing)6:05 PM ETSep 162 daysMancini AnthonySee RemarksSSale−1.77K$199.24−$353.4K−4.0%42.1K after2 lots10b5-1
Sep 18, 2026 (view filing)6:04 PM ETSep 162 daysKelsey Stephen MichaelSee RemarksSSale−5.57K$199.24−$1.11M−1.9%286.3K after2 lots10b5-1
Sep 18, 2026 (view filing)6:03 PM ETSep 162 daysHorn Margaret AChief Operating OfficerSSale−4.97K$199.24−$989.6K−3.2%149.7K after2 lots10b5-1
Sep 18, 2026 (view filing)6:02 PM ETSep 162 daysGoldsmith Mark ASee RemarksSSale−14.0K$199.24−$2.79M−5.2%253.3K after2 lots10b5-1
Sep 18, 2026 (view filing)6:01 PM ETSep 162 daysCislini JeffSVP & General CounselSSale−3.37K$199.24−$670.6K−6.0%52.5K after2 lots10b5-1
Sep 18, 2026 (view filing)6:00 PM ETSep 162 daysAnders JackChief Financial OfficerSSale−4.05K$199.24−$807.5K−3.3%119.2K after2 lots10b5-1
Sep 15, 2026 (view filing)6:00 PM ETSep 114 daysKelsey Stephen MichaelSee RemarksSSale−92.5K$202.36−$18.7M−24.1%291.9K after8 lots10b5-1
Sep 14, 2026 (view filing)6:03 PM ETSep 104 daysMancini AnthonySee RemarksSSale−15.4K$204.16−$3.15M−26.0%43.9K after5 lots10b5-1
Sep 10, 2026 (view filing)5:52 PM ETSep 82 daysKim Lorence H.DirectorSSale−17.1K$209.82−$3.59M−100.0%0 after7 lots10b5-1
Sep 2, 2026 (view filing)4:30 PM ETAug 312 daysKim Lorence H.DirectorSSale−56.0K$203.24−$11.4M−76.6%17.1K after7 lots10b5-1
Aug 25, 2026 (view filing)4:06 PM ETAug 214 daysCislini JeffGeneral CounselSSale−56.9K$209.24−$11.9M−50.4%55.9K after6 lots10b5-1
Aug 25, 2026 (view filing)4:06 PM ETAug 214 daysGoldsmith Mark ASee RemarksSSale−80.0K$209.20−$16.7M−23.0%267.3K after6 lots10b5-1
Aug 25, 2026 (view filing)4:06 PM ETAug 214 daysGoldsmith Mark ASee RemarksSSale−6.00K$209.20−$1.26M−8.9%61.4K after12 lots10b5-1
Jul 1, 2026 (view filing)6:25 PM ETJun 292 daysPatel SushilDirectorSSale−5.58K$187.99−$1.05M−20.5%21.7K after9 lots10b5-1
Jun 26, 2026 (view filing)Jun 242 daysAnders JackChief Financial OfficerSSale−20.0K$168.33−$3.37M−14.0%123.3K after4 lots10b5-1
Jun 18, 2026 (view filing)Jun 162 daysMancini AnthonySee RemarksSSale−4.62K$156.12−$720.5K−8.5%50.0K after
Jun 18, 2026 (view filing)Jun 162 daysGoldsmith Mark ASee RemarksSSale−10.0K$156.12−$1.56M−3.6%267.3K after10b5-1
Jun 18, 2026 (view filing)Jun 162 daysCislini JeffGeneral CounselSSale−2.16K$156.12−$336.8K−3.7%56.5K after10b5-1
Jun 18, 2026 (view filing)Jun 162 daysAnders JackChief Financial OfficerSSale−2.72K$156.12−$425.0K−2.2%123.3K after10b5-1
Jun 18, 2026 (view filing)Jun 162 daysKelsey Stephen MichaelSee RemarksSSale−4.17K$156.12−$651.8K−1.4%291.9K after10b5-1
Jun 17, 2026 (view filing)Jun 16, 2025-Jun 17, 2026366 daysLateHorn Margaret AChief Operating OfficerSSale−93.6K$160.00−$15.0M−37.7%154.6K after3 lots10b5-1
Jun 15, 2026 (view filing)Jun 114 daysHorn Margaret AChief Operating OfficerSSale−10.0K$148.01−$1.48M−5.9%158.2K after7 lots10b5-1
May 28, 2026 (view filing)May 262 daysMancini AnthonySee RemarksSSale−3.12K$153.99−$480.6K−5.4%54.4K after3 lots10b5-1
Apr 29, 2026 (view filing)Apr 272 daysMancini AnthonySee RemarksSSale−3.12K$132.41−$413.1K−5.4%54.4K after3 lots10b5-1
Apr 17, 2026 (view filing)Apr 152 daysGoldsmith Mark ASee RemarksSSale−120.0K$150.09−$18.0M−30.2%276.7K after10b5-1
Mar 26, 2026 (view filing)Mar 251 dayMancini AnthonySee RemarksSSale−37.5K$95.57−$3.58M−40.8%54.4K after5 lots10b5-1
Mar 19, 2026 (view filing)Mar 172 daysWei LinChief Medical OfficerSSale−2.07K$99.48−$206.2K−2.0%101.4K after10b5-1
Mar 19, 2026 (view filing)Mar 172 daysKelsey Stephen MichaelSee RemarksSSale−4.30K$99.48−$428.0K−1.4%295.4K after10b5-1
Mar 19, 2026 (view filing)Mar 172 daysGoldsmith Mark ASee RemarksSSale−12.9K$99.48−$1.28M−4.4%276.7K after10b5-1
Mar 19, 2026 (view filing)Mar 172 daysHorn Margaret AChief Operating OfficerSSale−4.58K$99.48−$455.9K−2.8%157.6K after10b5-1
Mar 19, 2026 (view filing)Mar 172 daysAnders JackChief Financial OfficerSSale−2.75K$99.48−$273.9K−2.1%125.5K after10b5-1
Mar 19, 2026 (view filing)Mar 17-192 daysCislini JeffGeneral CounselSSale−2.96K$98.68−$291.9K−4.8%58.5K after2 lots10b5-1
Mar 19, 2026 (view filing)Mar 172 daysWang XiaolinSee RemarksSSale−2.01K$99.48−$200.0K−1.7%116.1K after10b5-1
Mar 3, 2026 (view filing)Mar 21 dayGoldsmith Mark ASee RemarksSSale−30.0K$101.22−$3.04M−9.4%289.6K after5 lots10b5-1
Mar 3, 2026 (view filing)Mar 21 dayGoldsmith Mark ASee RemarksSSale−6.00K$101.29−$607.8K−8.5%64.4K after8 lots10b5-1
Jan 23, 2026 (view filing)Jan 212 daysCislini JeffGeneral CounselSSale−908$115.60−$105.0K−1.9%47.0K after10b5-1
Jan 9, 2026 (view filing)Jan 72 daysHorn Margaret AChief Operating OfficerSSale−75.0K$100.56−$7.54M−34.7%141.1K after3 lots10b5-1
Jan 9, 2026 (view filing)Jan 72 daysAnders JackChief Financial OfficerSSale−10.0K$98.00−$980.0K−8.5%108.1K after10b5-1
Dec 18, 2025 (view filing)Dec 162 daysCislini JeffGeneral CounselSSale−2.69K$76.82−$206.5K−5.3%47.9K after10b5-1
Dec 18, 2025 (view filing)Dec 162 daysGoldsmith Mark ASee RemarksSSale−15.4K$76.82−$1.18M−6.2%232.5K after10b5-1
Dec 18, 2025 (view filing)Dec 162 daysKelsey Stephen MichaelSee RemarksSSale−5.45K$76.82−$418.4K−1.9%278.6K after10b5-1
Dec 18, 2025 (view filing)Dec 162 daysHorn Margaret AChief Operating OfficerSSale−4.85K$76.82−$372.3K−3.3%141.1K after10b5-1
Dec 18, 2025 (view filing)Dec 162 daysAnders JackChief Financial OfficerSSale−3.10K$77.09−$239.3K−2.8%108.1K after10b5-1
Nov 26, 2025 (view filing)Nov 251 dayAnders JackChief Financial OfficerSSale−5.42K$74.00−$400.9K−4.7%111.0K after10b5-1
Nov 26, 2025 (view filing)Nov 251 dayGoldsmith Mark ASee RemarksSSale−60.0K$75.08−$4.50M−19.5%247.9K after10b5-1
Nov 26, 2025 (view filing)Nov 251 dayGoldsmith Mark ASee RemarksSSale−6.00K$75.00−$450.0K−8.2%67.4K after2 lots10b5-1
Nov 20, 2025 (view filing)Nov 182 daysGoldsmith Mark ASee RemarksSSale−20.0K$70.38−$1.41M−7.5%247.9K after10b5-1